Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Johnson

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 13, 2009
Gynaecological surgery from art and craft to science?Neil Philip Johnson
The Australian & New Zealand Journal of Obstetrics & Gynaecology|April 28, 2006
No more surrogate end-points in randomised trials: the PCOSMIC trial protocol for women with polycystic ovary syndrome using metformin for infertility with clomipheneNeil Philip Johnson
The Lancet. Oncology|December 30, 2008
Sorafenib for liver cancer: the horizon broadensPhilip Johnson, Lucinda Billingham
BMJ Case Reports|April 16, 2013
Nocardia brasiliensis vertebral osteomyelitis and epidural abscessPhilip Johnson, Hussam Ammar
Journal of Hepatology|April 4, 2019
Trial endpoints for systemic therapy in patients with hepatocellular carcinomaTim Meyer, Philip Johnson
Asia-Pacific Journal of Clinical Oncology|April 25, 2012
Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: an Asian perspectiveStephen L Chan, Philip Johnson
Journal of AOAC International|December 6, 2017
Target Selection Strategies for LC-MS/MS Food Allergen MethodsMelanie L Downs, Philip Johnson
Journal of Hepatology|December 17, 2009
Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conferenceJean-François Dufour, Philip Johnson
The Australian & New Zealand Journal of Obstetrics & Gynaecology|March 14, 2009
Gynaecologists blaze the trail in primary studies and systematic reviews of diagnostic test accuracyNeil Philip Johnson, Khalid S Khan
Clinical Medicine (London, England)|September 22, 2007
New medical options for liver tumoursSarah Williams, Daniel Palmer, Philip Johnson
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 13, 2009
Gynaecological surgery from art and craft to science?Neil Philip Johnson
The Australian & New Zealand Journal of Obstetrics & Gynaecology|April 28, 2006
No more surrogate end-points in randomised trials: the PCOSMIC trial protocol for women with polycystic ovary syndrome using metformin for infertility with clomipheneNeil Philip Johnson
The Lancet. Oncology|December 30, 2008
Sorafenib for liver cancer: the horizon broadensPhilip Johnson, Lucinda Billingham
BMJ Case Reports|April 16, 2013
Nocardia brasiliensis vertebral osteomyelitis and epidural abscessPhilip Johnson, Hussam Ammar
Journal of Hepatology|April 4, 2019
Trial endpoints for systemic therapy in patients with hepatocellular carcinomaTim Meyer, Philip Johnson
Asia-Pacific Journal of Clinical Oncology|April 25, 2012
Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: an Asian perspectiveStephen L Chan, Philip Johnson
Journal of AOAC International|December 6, 2017
Target Selection Strategies for LC-MS/MS Food Allergen MethodsMelanie L Downs, Philip Johnson
Journal of Hepatology|December 17, 2009
Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conferenceJean-François Dufour, Philip Johnson
The Australian & New Zealand Journal of Obstetrics & Gynaecology|March 14, 2009
Gynaecologists blaze the trail in primary studies and systematic reviews of diagnostic test accuracyNeil Philip Johnson, Khalid S Khan
Clinical Medicine (London, England)|September 22, 2007
New medical options for liver tumoursSarah Williams, Daniel Palmer, Philip Johnson
Pageof 10